Distribution patterns of HLA-A<sup>*</sup>, B<sup>*</sup>, DRB1<sup>*</sup> allele groups among persons who underwent COVID-19

The main histocompatibility complex — HLA system (Human Leukocyte Antigens) is among the most important genetic factors determining response of humans to infectious agents. The key role that HLA molecules play in immune response is to present the pathogen-derived peptides. Enormous molecular variabi...

Full description

Saved in:
Bibliographic Details
Main Authors: L. N. Bubnova, I. E. Pavlova, A. S. Berkos, M. A. Terentyeva, T. V. Glazanova, L. V. Erokhina, E. V. Belyaeva, A. V. Chechetkin, N. S. Bashketova, I. G. Chkhindzheria, M. А. Kozhemyakina, D. V. Azarov, R. N. Kuznetsova, Areg A. Totolyan
Format: Article
Language:Russian
Published: St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2021-06-01
Series:Медицинская иммунология
Subjects:
Online Access:https://www.mimmun.ru/mimmun/article/view/2334
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849401623167631360
author L. N. Bubnova
I. E. Pavlova
A. S. Berkos
M. A. Terentyeva
T. V. Glazanova
L. V. Erokhina
E. V. Belyaeva
A. V. Chechetkin
N. S. Bashketova
I. G. Chkhindzheria
M. А. Kozhemyakina
D. V. Azarov
R. N. Kuznetsova
Areg A. Totolyan
author_facet L. N. Bubnova
I. E. Pavlova
A. S. Berkos
M. A. Terentyeva
T. V. Glazanova
L. V. Erokhina
E. V. Belyaeva
A. V. Chechetkin
N. S. Bashketova
I. G. Chkhindzheria
M. А. Kozhemyakina
D. V. Azarov
R. N. Kuznetsova
Areg A. Totolyan
author_sort L. N. Bubnova
collection DOAJ
description The main histocompatibility complex — HLA system (Human Leukocyte Antigens) is among the most important genetic factors determining response of humans to infectious agents. The key role that HLA molecules play in immune response is to present the pathogen-derived peptides. Enormous molecular variability of HLA alleles in human populations have attracted close attention and became the basis for numerous studies aimed at evaluating the role of HLA genotypes for individual features of immune response to COVID-19, the new infection caused by SARS-CoV-2 β-coronavirus. Many studies have focused on search of specific alleles associated with both susceptibility and resistance to this disease. Separate HLA patterns were reported already. These patterns may be either universal to several populations, or rather peculiar, since distribution of HLA genes is different for various populations, depending on the living conditions, including specific protection from environmental pathogens. Therefore, it is evident that individual effects of HLA genotype upon occurrence and course of SARS-CoV-2 infection should be performed in comparison with the HLA distribution among the residents of appropriate region. The objective of this study was to compare the distribution of HLA-A*, B*, DRB1* allele groups, and to analyze the frequencies of HLA-AB-DRB1 haplotypes in subjects with COVID-19 (n = 138), compared with the control group presented by residents of the North-Western Russia (n = 1456). The most significant differences between COVID-19 patients compared with a group from control population were revealed for the groups of HLA-A* alleles: the frequencies of HLA-A*02 and HLA-A*26 were significantly reduced (39.86% versus 51.72%, χ2 = 7,58, and 4.35% versus 9.07%, χ2 = 4.17, respectively). At the same time, the frequency of HLA-A*29 was increased more than 2-fold (5.80% versus 2.47%, χ2 = 4.03). This finding suggests that the allele groups A*02 and A*26 are associated with reduced likelihood of the disease, while A*29, is an apparent factor predisposing for susceptibility to the disease. It was found that occurrence of definite HLA haplotypes, including the A*02 allele group, is less common in persons who have undergone COVID-19, and are ranged at the 4th, 7th and 10th positions in frequency, while in the population control group such HLA haplotypes took the 3rd, 4th, 7th and 8th places. Further evaluation of the HLA gene polymorphism will allow to understand the predetermined immunogenetic basis for susceptibility, as well as clinical severity of COVID-19.
format Article
id doaj-art-1fe9db40b6c64aadbbf23525c321c41b
institution Kabale University
issn 1563-0625
2313-741X
language Russian
publishDate 2021-06-01
publisher St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
record_format Article
series Медицинская иммунология
spelling doaj-art-1fe9db40b6c64aadbbf23525c321c41b2025-08-20T03:37:44ZrusSt. Petersburg branch of the Russian Association of Allergologists and Clinical ImmunologistsМедицинская иммунология1563-06252313-741X2021-06-0123352353210.15789/1563-0625-DPO-23341401Distribution patterns of HLA-A<sup>*</sup>, B<sup>*</sup>, DRB1<sup>*</sup> allele groups among persons who underwent COVID-19L. N. Bubnova0I. E. Pavlova1A. S. Berkos2M. A. Terentyeva3T. V. Glazanova4L. V. Erokhina5E. V. Belyaeva6A. V. Chechetkin7N. S. Bashketova8I. G. Chkhindzheria9M. А. Kozhemyakina10D. V. Azarov11R. N. Kuznetsova12Areg A. Totolyan13Russian Research Institute of Haematology and Transfusiology, Federal Medical-Bilogical Agency; First St. Petersburg State I. Pavlov Medical UniversityRussian Research Institute of Haematology and Transfusiology, Federal Medical-Bilogical AgencyRussian Research Institute of Haematology and Transfusiology, Federal Medical-Bilogical AgencyRussian Research Institute of Haematology and Transfusiology, Federal Medical-Bilogical AgencyRussian Research Institute of Haematology and Transfusiology, Federal Medical-Bilogical AgencyRussian Research Institute of Haematology and Transfusiology, Federal Medical-Bilogical AgencyRussian Research Institute of Haematology and Transfusiology, Federal Medical-Bilogical AgencyRussian Research Institute of Haematology and Transfusiology, Federal Medical-Bilogical AgencyDepartment of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing in St. PetersburgDepartment of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing in St. PetersburgCenter for Hygiene and Epidemiology in St. PetersburgCenter for Hygiene and Epidemiology in St. PetersburgFirst St. Petersburg State I. Pavlov Medical University; St. Petersburg Pasteur Research Institute of Epidemiology and MicrobiologyFirst St. Petersburg State I. Pavlov Medical University; St. Petersburg Pasteur Research Institute of Epidemiology and MicrobiologyThe main histocompatibility complex — HLA system (Human Leukocyte Antigens) is among the most important genetic factors determining response of humans to infectious agents. The key role that HLA molecules play in immune response is to present the pathogen-derived peptides. Enormous molecular variability of HLA alleles in human populations have attracted close attention and became the basis for numerous studies aimed at evaluating the role of HLA genotypes for individual features of immune response to COVID-19, the new infection caused by SARS-CoV-2 β-coronavirus. Many studies have focused on search of specific alleles associated with both susceptibility and resistance to this disease. Separate HLA patterns were reported already. These patterns may be either universal to several populations, or rather peculiar, since distribution of HLA genes is different for various populations, depending on the living conditions, including specific protection from environmental pathogens. Therefore, it is evident that individual effects of HLA genotype upon occurrence and course of SARS-CoV-2 infection should be performed in comparison with the HLA distribution among the residents of appropriate region. The objective of this study was to compare the distribution of HLA-A*, B*, DRB1* allele groups, and to analyze the frequencies of HLA-AB-DRB1 haplotypes in subjects with COVID-19 (n = 138), compared with the control group presented by residents of the North-Western Russia (n = 1456). The most significant differences between COVID-19 patients compared with a group from control population were revealed for the groups of HLA-A* alleles: the frequencies of HLA-A*02 and HLA-A*26 were significantly reduced (39.86% versus 51.72%, χ2 = 7,58, and 4.35% versus 9.07%, χ2 = 4.17, respectively). At the same time, the frequency of HLA-A*29 was increased more than 2-fold (5.80% versus 2.47%, χ2 = 4.03). This finding suggests that the allele groups A*02 and A*26 are associated with reduced likelihood of the disease, while A*29, is an apparent factor predisposing for susceptibility to the disease. It was found that occurrence of definite HLA haplotypes, including the A*02 allele group, is less common in persons who have undergone COVID-19, and are ranged at the 4th, 7th and 10th positions in frequency, while in the population control group such HLA haplotypes took the 3rd, 4th, 7th and 8th places. Further evaluation of the HLA gene polymorphism will allow to understand the predetermined immunogenetic basis for susceptibility, as well as clinical severity of COVID-19.https://www.mimmun.ru/mimmun/article/view/2334major hystocompatibility complexhlaalleleshaplotypes
spellingShingle L. N. Bubnova
I. E. Pavlova
A. S. Berkos
M. A. Terentyeva
T. V. Glazanova
L. V. Erokhina
E. V. Belyaeva
A. V. Chechetkin
N. S. Bashketova
I. G. Chkhindzheria
M. А. Kozhemyakina
D. V. Azarov
R. N. Kuznetsova
Areg A. Totolyan
Distribution patterns of HLA-A<sup>*</sup>, B<sup>*</sup>, DRB1<sup>*</sup> allele groups among persons who underwent COVID-19
Медицинская иммунология
major hystocompatibility complex
hla
alleles
haplotypes
title Distribution patterns of HLA-A<sup>*</sup>, B<sup>*</sup>, DRB1<sup>*</sup> allele groups among persons who underwent COVID-19
title_full Distribution patterns of HLA-A<sup>*</sup>, B<sup>*</sup>, DRB1<sup>*</sup> allele groups among persons who underwent COVID-19
title_fullStr Distribution patterns of HLA-A<sup>*</sup>, B<sup>*</sup>, DRB1<sup>*</sup> allele groups among persons who underwent COVID-19
title_full_unstemmed Distribution patterns of HLA-A<sup>*</sup>, B<sup>*</sup>, DRB1<sup>*</sup> allele groups among persons who underwent COVID-19
title_short Distribution patterns of HLA-A<sup>*</sup>, B<sup>*</sup>, DRB1<sup>*</sup> allele groups among persons who underwent COVID-19
title_sort distribution patterns of hla a sup sup b sup sup drb1 sup sup allele groups among persons who underwent covid 19
topic major hystocompatibility complex
hla
alleles
haplotypes
url https://www.mimmun.ru/mimmun/article/view/2334
work_keys_str_mv AT lnbubnova distributionpatternsofhlaasupsupbsupsupdrb1supsupallelegroupsamongpersonswhounderwentcovid19
AT iepavlova distributionpatternsofhlaasupsupbsupsupdrb1supsupallelegroupsamongpersonswhounderwentcovid19
AT asberkos distributionpatternsofhlaasupsupbsupsupdrb1supsupallelegroupsamongpersonswhounderwentcovid19
AT materentyeva distributionpatternsofhlaasupsupbsupsupdrb1supsupallelegroupsamongpersonswhounderwentcovid19
AT tvglazanova distributionpatternsofhlaasupsupbsupsupdrb1supsupallelegroupsamongpersonswhounderwentcovid19
AT lverokhina distributionpatternsofhlaasupsupbsupsupdrb1supsupallelegroupsamongpersonswhounderwentcovid19
AT evbelyaeva distributionpatternsofhlaasupsupbsupsupdrb1supsupallelegroupsamongpersonswhounderwentcovid19
AT avchechetkin distributionpatternsofhlaasupsupbsupsupdrb1supsupallelegroupsamongpersonswhounderwentcovid19
AT nsbashketova distributionpatternsofhlaasupsupbsupsupdrb1supsupallelegroupsamongpersonswhounderwentcovid19
AT igchkhindzheria distributionpatternsofhlaasupsupbsupsupdrb1supsupallelegroupsamongpersonswhounderwentcovid19
AT makozhemyakina distributionpatternsofhlaasupsupbsupsupdrb1supsupallelegroupsamongpersonswhounderwentcovid19
AT dvazarov distributionpatternsofhlaasupsupbsupsupdrb1supsupallelegroupsamongpersonswhounderwentcovid19
AT rnkuznetsova distributionpatternsofhlaasupsupbsupsupdrb1supsupallelegroupsamongpersonswhounderwentcovid19
AT aregatotolyan distributionpatternsofhlaasupsupbsupsupdrb1supsupallelegroupsamongpersonswhounderwentcovid19